Viridian Therapeutics

Pharma

On-body injected version of Amgen's Tepezza measures up to IV

A phase 3 trial has shown that subcutaneous injection of Amgen's Tepezza can provide comparable performance to its current route of IV administration.

Kevin Dunleavy Apr 6, 2026 9:43am